LIR Life Sciences Corp. (CSE:SKNY)
Canada · Delayed Price · Currency is CAD 0.2200
0.00 (0.00%)
Oct 6, 2026, 12:16 PM EST
LIR Life Sciences Statistics
Total Valuation
CSE:SKNY has a market cap or net worth of CAD 6.31 million. The enterprise value is 6.11 million.
| Market Cap | 6.31M |
| Enterprise Value | 6.11M |
Important Dates
The next estimated earnings date is Thursday, December 24, 2026.
| Earnings Date | Dec 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:SKNY has 28.67 million shares outstanding. The number of shares has increased by 154.80% in one year.
| Current Share Class | 28.67M |
| Shares Outstanding | 28.67M |
| Shares Change (YoY) | +154.80% |
| Shares Change (QoQ) | +1.62% |
| Owned by Insiders (%) | 11.00% |
| Owned by Institutions (%) | n/a |
| Float | 25.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 89.83 |
| P/TBV Ratio | 89.83 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.29
| Current Ratio | 1.29 |
| Quick Ratio | 1.26 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -1,247.97% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -6,092.74% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.26 |
| 200-Day Moving Average | 0.79 |
| Relative Strength Index (RSI) | 49.18 |
| Average Volume (20 Days) | 27,509 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -11,667 |
| Operating Income | -4.28M |
| Pretax Income | -4.75M |
| Net Income | -4.75M |
| EBITDA | -4.27M |
| EBIT | -4.28M |
| Earnings Per Share (EPS) | -0.18 |
Balance Sheet
The company has 201,191 in cash and no debt, with a net cash position of 201,191 or 0.01 per share.
| Cash & Cash Equivalents | 201,191 |
| Total Debt | n/a |
| Net Cash | 201,191 |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 70,210 |
| Book Value Per Share | 0.00 |
| Working Capital | 70,210 |
Cash Flow
| Operating Cash Flow | -2.39M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 5,167 |
| Net Borrowing | 5,000 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:SKNY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -154.80% |
| Shareholder Yield | -154.80% |
| Earnings Yield | -75.28% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 7, 2025. It was a reverse split with a ratio of 0.6666667.
| Last Split Date | Nov 7, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.6666667 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |